ALK’s history can be traced back to 1923 when it all started in a small laboratory in Copenhagen, Denmark.
Since then, ALK has become a research-driven, global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. In addition, ALK is the foremost innovators in allergy immunotherapy; a unique treatment, which reduces allergic symptoms and treats the cause of allergy.
ALK employs 2,300 employees worldwide and has affiliates, production facilities and distributors around the globe. Today, around 1.5 million people worldwide use ALK products.
ALK has an unrivalled understanding of allergens (especially house dust mites) and how they affect the human body, as well as the link between allergy and respiratory diseases such as asthma.
Pharma Solutions is the marketing partner for ALK range of products in the Gulf & the Middle East.